%0 Journal Article
%T Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial
%A Zdenkowski, N.
%A Forbes, J.F.
%A Boyle, F.M.
%A Kannourakis, G.
%A Gill, P.G.
%A Bayliss, E.
%A Saunders, C.
%A Della-Fiorentina, S.
%A Kling, N.
%A Campbell, I.
%A Mann, G.B.
%A Coates, A.S.
%A Gebski, V.
%A Davies, L.
%A Thornton, R.
%A Reaby, L.
%A Cuzick, J.
%A Green, M.
%A ,
%J Annals of Oncology
%@ 0923-7534
%D 2016-05-01
%I Elsevier BV
%~ DeepDyve